Jack O'Meara, CEO will be presenting Ochre Bio Ltd. at the upcoming European Life Sciences CEO Forum.

Ochre Bio develops genomic medicines for cardiometabolic disease. EIT Health company.

e-Meet Ochre Bio Ltd. at #Sachs_ELSF

More info @ https://t.co/YXBF2fDncZ pic.twitter.com/6auaHAxCF8

— Sachs Associates (@SachsAssociates) February 10, 2021